logo
US aid cuts halt HIV vaccine research in South Africa, with global impact

US aid cuts halt HIV vaccine research in South Africa, with global impact

The Mainichi13-07-2025
JOHANNESBURG (AP) -- Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived.
Stop all work, it said. The United States under the Trump administration was withdrawing all its funding.
The news devastated the researchers, who live and work in a region where more people live with HIV than anywhere else in the world. Their research project, called BRILLIANT, was meant to be the latest to draw on the region's genetic diversity and deep expertise in the hope of benefiting people everywhere.
But the $46 million from the U.S. for the project was disappearing, part of the dismantling of foreign aid by the world's biggest donor earlier this year as President Donald Trump announced a focus on priorities at home.
South Africa hit hard by aid cuts
South Africa has been hit especially hard because of Trump's baseless claims about the targeting of the country's white Afrikaner minority. The country had been receiving about $400 million a year via USAID and the HIV-focused PEPFAR.
Now that's gone.
Glenda Grey, who heads the Brilliant program, said the African continent has been vital to the development of HIV medication, and the U.S. cuts threaten its capability to do such work in the future.
Significant advances have included clinical trials for lenacapavir, the world's only twice-a-year shot to prevent HIV, recently approved for use by the U.S. Food and Drug Administration. One study to show its efficacy involved young South Africans.
"We do the trials better, faster and cheaper than anywhere else in the world, and so without South Africa as part of these programs, the world, in my opinion, is much poorer," Gray said.
She noted that during the urgency of the COVID-19 pandemic, South Africa played a crucial role by testing the Johnson & Johnson and Novavax vaccines, and South African scientists' genomic surveillance led to the identification of an important variant.
Labs empty and thousands are laid off
A team of researchers at the University of the Witwatersrand has been part of the unit developing the HIV vaccines for the trials.
Inside the Wits laboratory, technician Nozipho Mlotshwa was among the young people in white gowns working on samples, but she may soon be out of a job.
Her position is grant-funded. She uses her salary to support her family and fund her studies in a country where youth unemployment hovers around 46%.
"It's very sad and devastating, honestly," she said of the U.S. cuts and overall uncertainty. "We'll also miss out collaborating with other scientists across the continent."
Professor Abdullah Ely leads the team of researchers. He said the work had promising results indicating that the vaccines were producing an immune response.
But now that momentum, he said, has "all kind of had to come to a halt."
The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped. South Africa's health department says about 100 researchers for that program and others related to HIV have been laid off. Funding for postdoctoral students involved in experiments for the projects is at risk.
South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research funding over the next five years due to the aid cuts, which affect not only work on HIV but also tuberculosis -- another disease with a high number of cases in the country.
Less money, and less data on what's affected
South Africa's government has said it will be very difficult to find funding to replace the U.S. support.
And now the number of HIV infections will grow. Medication is more difficult to obtain. At least 8,000 health workers in South Africa's HIV program have already been laid off, the government has said. Also gone are the data collectors who tracked patients and their care, as well as HIV counselors who could reach vulnerable patients in rural communities.
For researchers, Universities South Africa, an umbrella body, has applied to the national treasury for over $110 million for projects at some of the largest schools.
During a visit to South Africa in June, UNAIDS executive director Winnie Byanyima was well aware of the stakes, and the lives at risk, as research and health care struggle in South Africa and across Africa at large.
Other countries that were highly dependent on U.S. funding including Zambia, Nigeria, Burundi and Ivory Coast are already increasing their own resources, she said.
"But let's be clear, what they are putting down will not be funding in the same way that the American resources were funding," Byanyima said.
___
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

More than 20% of NASA employees opt to leave agency: US media
More than 20% of NASA employees opt to leave agency: US media

NHK

time2 hours ago

  • NHK

More than 20% of NASA employees opt to leave agency: US media

US media outlets say nearly 4,000 employees have applied to leave the NASA space agency under a program by President Donald Trump's administration to cut federal spending. CBS News and other media have reported that 3,870 staff, or over 20 percent of NASA's workforce, have applied to leave. The agency employs about 18,000 people. The reports said the deadline for applications for the deferred resignation program was on Friday. The Trump administration says NASA will face a 24-percent year-on-year reduction in the budget for the fiscal year that begins in October. About 360 current and former employees of the agency published an open letter on Monday last week to voice their opposition to the spending cuts. The "Voyager Declaration" says, "The last six months have seen rapid and wasteful changes which have undermined our mission and caused catastrophic impacts on NASA's workforce."

‘Fantastic Four: First Steps' scores Marvel's first $100 million box office opening of 2025
‘Fantastic Four: First Steps' scores Marvel's first $100 million box office opening of 2025

Japan Today

time8 hours ago

  • Japan Today

‘Fantastic Four: First Steps' scores Marvel's first $100 million box office opening of 2025

This image released by Disney shows Pedro Pascal in a scene from "The Fantastic Four: First Steps." (Marvel/Disney via AP) By LINDSEY BAHR and ITZEL LUNA Marvel's first family has finally found box office gold. 'The Fantastic Four: First Steps,' the first film about the superheroes made under the guidance of Kevin Feige and the Walt Disney Co., earned $118 million in its first weekend in 4,125 North American theaters, according to studio estimates Sunday. That makes it the fourth biggest opening of the year, behind 'A Minecraft Movie,' 'Lilo & Stitch' and 'Superman,' and the biggest Marvel opening since 'Deadpool & Wolverine' grossed $211 million out of the gate last summer. Internationally, 'Fantastic Four' made $100 million from 52 territories, adding up to a $218 million worldwide debut. The numbers were within the range the studio was expecting. The film arrived in the wake of another big superhero reboot, James Gunn's 'Superman,' which opened three weekends ago and has already crossed $500 million globally. That film, from the other main player in comic book films, DC Studios, took second place with $24.9 million domestically. The box office success of 'First Steps' and 'Superman' means 'the whole notion of superhero fatigue, which has been talked about a lot, can I think be put to rest. I always say it's bad movie fatigue, not superhero fatigue,' said Paul Dergarabedian, senior media analyst for data firm Comscore. 'First Steps' is the latest attempt at bringing the superhuman family to the big screen, following lackluster performances for other versions. The film, based on the original Marvel comics, is set during the 1960s in a retro-futuristic world led by the Fantastic Four, a family of astronauts-turned-superhuman from exposure to cosmic rays during a space mission. The family is made up of Reed Richards (Pedro Pascal), who can stretch his body to incredible lengths; Sue Storm (Vanessa Kirby), who can render herself invisible; Johnny Storm (Joseph Quinn), who transforms into a fiery human torch; and Ben Grimm (Ebon Moss-Bachrach), who possesses tremendous superhuman strength with his stone-like flesh. The movie takes place four years after the family gained powers, during which Reed's inventions have transformed technology, and Sue's diplomacy has led to global peace. Both audiences and critics responded positively to the film, which currently has an 88% on Rotten Tomatoes and promising exit poll responses from opening weekend ticket buyers. An estimated 46% of audiences chose to see it on premium screens, including IMAX and other large formats. The once towering Marvel is working to rebuild audience enthusiasm for its films and characters. Its two previous offerings this year did not reach the cosmic box office heights of 'Deadpool & Wolverine," which made over $1.3 billion, or those of the 'Avengers'-era. But critically, the films have been on an upswing since the poorly reviewed 'Captain America: Brave New World,' which ultimately grossed $415 million worldwide. 'Thunderbolts," which jumpstarted the summer movie season, was better received critically but financially is capping out at just over $382 million globally. Like Deadpool and Wolverine, the Fantastic Four characters had been under the banner of 20th Century Fox for years. The studio produced two critically loathed, but decently profitable attempts in the mid-2000s with future Captain America Chris Evans as the Human Torch. In 2015, it tried again (unsuccessfully) with Michael B. Jordan and Miles Teller. They got another chance after Disney's $71 billion acquisition of Fox's entertainment assets in 2019. The 'Fantastic Four's' opening weekend results were a little less than some rival studio projections, Dergarabedian said. Nonetheless, the film is expected to carry movie theater earnings well into August. Holdovers dominated the top 10, but one other newcomer managed to make the chart. The dark romantic comedy 'Oh, Hi!' earned $1.1 million from 866 screens. 'Jurassic World Rebirth' landed in third place in its fourth weekend with $13 million, followed by 'F1' with $6.2 million. The Brad Pitt racing movie also passed $500 million globally. 'Smurfs' rounded out the top five with $5.4 million in its second weekend. The box office is currently up over 12% from last year. With final domestic figures being released Monday, this list factors in the estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Comscore: 'The Fantastic Four: First Steps,' $118 million. 'Superman,' $24.9 million. 'Jurassic World Rebirth,' $13 million. 'F1: The Movie,' $6.2 million. 'Smurfs,' $5.4 million. 'I Know What You Did Last Summer,' $5.1 million. 'How to Train Your Dragon,' $2.8 million. 'Eddington,' $1.7 million. 'Saiyaara,' $1.3 million. 'Oh, Hi!,' $1.1 million. © Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Japan's bad medicine for its bad romance problem
Japan's bad medicine for its bad romance problem

Nikkei Asia

timea day ago

  • Nikkei Asia

Japan's bad medicine for its bad romance problem

Parents stand with their baby on a pedestrian bridge near Mita Station in Tokyo. The average number of births per woman in Japan was just 1.15 in 2024. © AP Waka Ikeda is a Tokyo-based freelance journalist covering society, culture and the movie industry. In the late 1980s, Bon Jovi released "Bad Medicine," a song about a toxic relationship. Nearly four decades on, Japan faces its own "bad medicine" epidemic: government-prescribed dating apps, speed-dating events and marriage seminars aimed at curing a national romance crisis. But like the song's doomed love affair, these taxpayer-funded remedies may be making things worse -- offering solutions to a generation too paralyzed by self-doubt to embrace them.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store